BRIEF published on 03/27/2025 at 10:04, 10 days 22 hours ago RHÖN-KLINIKUM AG Reports Strong Financial Year Amid Leadership Change Strategic Partnerships Financial Performance Leadership Change Sustainability Targets Healthcare Growth
BRIEF published on 11/07/2024 at 09:04, 4 months 29 days ago RHÖN-KLINIKUM AG affiche des progrès constants au troisième trimestre 2024 Croissance Des Revenus Perspectives Financières Secteur De La Santé Résultats Du 3ème Trimestre 2024 Clinique RHÖN AG
BRIEF published on 11/07/2024 at 09:04, 4 months 29 days ago RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024 Revenue Growth Healthcare Sector Financial Outlook RHÖN-KLINIKUM AG Q3 2024 Results
PRESS RELEASE published on 11/07/2024 at 08:59, 4 months 29 days ago RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed RHÖN-KLINIKUM AG reports increased revenues and profit in the first nine months of 2024. EBITDA up by 2.3%. Outlook for 2024 confirmed amidst global uncertainties Revenues EBITDA Outlook Profit RHÖN-KLINIKUM AG
BRIEF published on 08/08/2024 at 09:05, 7 months 29 days ago Premier semestre 2024 : RHÖN-KLINIKUM AG poursuit sa bonne performance commerciale – perspectives confirmées Hausse Des Revenus Secteur De La Santé RHÖN-KLINIKUM AG Résultats Financiers 2024 Augmentation Des Bénéfices
BRIEF published on 08/08/2024 at 09:05, 7 months 29 days ago First Half of 2024: RHÖN-KLINIKUM AG Continues Good Business Performance – Outlook Confirmed Revenue Growth Healthcare Sector Profit Increase RHÖN-KLINIKUM AG 2024 Financial Results
PRESS RELEASE published on 08/08/2024 at 09:00, 7 months 29 days ago First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed RHÖN-KLINIKUM AG reports 6.5% revenue increase and 68.9% profit growth in first half of 2024. Outlook for 2024 remains positive amid global uncertainties Revenue Increase Healthcare Sector Outlook 2024 Profit Growth RHÖN-KLINIKUM AG
BRIEF published on 05/08/2024 at 09:04, 10 months 29 days ago RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results 2024 Outlook Healthcare Industry Economic Impact RHÖN-KLINIKUM AG Q1 Financial Results
BRIEF published on 05/08/2024 at 09:04, 10 months 29 days ago RHÖN-KLINIKUM AG annonce un bon début d'année 2024 avec des résultats positifs au premier trimestre Perspectives 2024 L'industrie De La Santé Impact Economique RHÖN-KLINIKUM AG Résultats Financiers Du Premier Trimestre
PRESS RELEASE published on 05/08/2024 at 08:59, 10 months 29 days ago RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
Published on 04/07/2025 at 08:00, 18 minutes ago Pulsar Helium Announces Notice of 2025 Annual General and Special Meeting of Shareholders
Published on 04/07/2025 at 00:05, 8 hours 13 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 6 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 08:00, 17 minutes ago Cairn Homes Plc: Issue of Equity for Vesting of share awards under the Cairn Homes plc Long Term Incentive Plan
Published on 04/07/2025 at 07:03, 1 hour 14 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 1 hour 17 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/07/2025 at 07:01, 1 hour 17 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 1 hour 17 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 14 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
